Guillaume Corre

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Muscular Dystrophy

Oxidative Stress

Top Venues

Nature communications

Scientific reports

Science translational medicine

GENETHON

École Pratique des Hautes Études (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GENETHON Jan 01 2017

France

Research Engineer bioinformatics :: IMBI

Genethon - Jan 01 2017

France

PostDoc

INSERM

France

PostDoc :: 951

INSERM

France

PhD student :: 951

Education History

École Pratique des Hautes Études Sep 01 2008 - Jun 27 2011

France

PHD

Université de Bretagne Occidentale

France

MSC

Publications

Juliette Lemoine, Auriane Dubois, Alan Dorval, Abbass Jaber, Ganesh Warthi, Kamel Mamchaoui, Tao Wang, Guillaume Corre, Matteo Bovolenta, Isabelle Richard
Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system. Scientific reports 14 (1) (2024)
Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J Lenting, Jean-Paul Concordet, Magali Toueille, Annarita Miccio, Mario Amendola
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature communications 11 (1) (2020)
Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J Lenting, Jean-Paul Concordet, Magali Toueille, Annarita Miccio, Mario Amendola
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature communications 11 (1) (2020)
William Lostal, Carinne Roudaut, Marine Faivre, Karine Charton, Laurence Suel, Nathalie Bourg, Heather Best, John Edward Smith, Jochen Gohlke, Guillaume Corre, Xidan Li, Zaher ElBeck, Ralph Knoell, Jack-Yves Deschamps, Henk Granzier, Isabelle Richard
Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A. Science translational medicine 11 (520) (2020)